Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Gallamine triethiodide AI simulator
(@Gallamine triethiodide_simulator)
Hub AI
Gallamine triethiodide AI simulator
(@Gallamine triethiodide_simulator)
Gallamine triethiodide
Gallamine triethiodide (Flaxedil) is a non-depolarising muscle relaxant. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. Gallamine is a non-depolarising type of blocker as it binds to the acetylcholine receptor but does not have the biological activity of acetyl choline. Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve, which causes tachycardia and occasionally hypertension. Very high doses cause histamine release.[citation needed]. Presence of iodine in the triethiodide salt makes it radio opaque.
Gallamine triethiodide was commonly used to prevent muscle contractions during surgical procedures, but is now superseded by new neuromuscular blocking drugs with fewer side effects.
It was developed by Daniel Bovet in 1947.
The drug is no longer marketed in the United States, according to the FDA Orange Book.
Gallamine triethiodide
Gallamine triethiodide (Flaxedil) is a non-depolarising muscle relaxant. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. Gallamine is a non-depolarising type of blocker as it binds to the acetylcholine receptor but does not have the biological activity of acetyl choline. Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve, which causes tachycardia and occasionally hypertension. Very high doses cause histamine release.[citation needed]. Presence of iodine in the triethiodide salt makes it radio opaque.
Gallamine triethiodide was commonly used to prevent muscle contractions during surgical procedures, but is now superseded by new neuromuscular blocking drugs with fewer side effects.
It was developed by Daniel Bovet in 1947.
The drug is no longer marketed in the United States, according to the FDA Orange Book.
Recent media
Recent media